Skip to main content

Table 3 Relationship (Spearman’s correlations) of UFS-QOL scale scores with bleeding diary assessments in VENUS I and VENUS II and PGI-I in VENUS II after 12 weeks of treatment; per protocol population (patient-reported outcome approach)

From: Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL)

 

VENUS I

VENUS II

UFS-QOL

Bleeding daysa

Heavy bleeding daysb

Bleeding daysa

Heavy bleeding daysb

PGI-I

Symptom Severity

0.59

0.56

0.62

0.60

0.69

Concern

−0.61

−0.58

−0.63

−0.63

−0.70

Activities

−0.63

−0.63

−0.54

−0.58

−0.67

Revised Activities

−0.63

−0.63

−0.53

−0.57

−0.66

Energy/Mood

−0.56

−0.58

−0.44

−0.51

−0.57

Control

−0.49

−0.54

−0.46

−0.52

−0.58

Self-Consciousness

−0.43

−0.41

−0.42

−0.47

−0.53

Sexual Function

−0.44

−0.47

−0.35

−0.40

−0.48

HRQoL Total

−0.61

−0.62

−0.53

−0.58

−0.66

  1. All p < 0.0001
  2. aNumber of days in previous 35 days – “bleeding”: days with rating of “bleeding” and “heavy bleeding”
  3. b“Heavy bleeding”: days with rating of “heavy bleeding”. HRQoL health-related quality of life; PGI-I Patient Global Impression of Improvement scale; UFS-QOL Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire